Project Details
Description
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oral Inhalation of Seralutinib for the Treatment of Pulmonary Arterial Hypertension (PAH)
| Status | Active |
|---|---|
| Effective start/end date | 2/20/24 → 7/31/33 |
Funding
- GOSSAMER BIO, INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.